← Back to headlines
CVS Health Reaches Insulin Pricing Settlement with FTC Amid Regulatory Scrutiny
CVS Health has reached a settlement with the Federal Trade Commission (FTC) concerning a case related to its insulin pricing practices, as pharmacy benefit managers face increasing scrutiny from regulators and lawmakers over their drug pricing methods.
24 Mar, 16:41 — 24 Mar, 18:18
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (51/100)3 sources25/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
cnbc
Center1
Center (1)
Reuters
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
US2Intl1
Sources
Showing 2 of 3 sources
ReutersVery High5h ago
CVS reaches insulin pricing settlement with FTC - Reuters
CVS reaches insulin pricing settlement with FTC Reuters
Read full article →cnbcMostly Factual4h ago
CVS reaches insulin pricing settlement with FTC
Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced scrutiny from regulators and lawmakers over pricing practices.
Read full article →Coverage Timeline
First report: Reuters · 24 Mar, 16:41|Full coverage: 3 · 2h|Window: 2h
Left-leaningCenterRight-leaning
Related Stories
Philippine President Marcos Declares Energy Emergency, Rolls Out Subsidies, and Eyes Joint Gas Development Amid Oil Crisis
just now
President oversees rollout of fuel subsidies
just now
Gov’t allots P20B to buy 2 million barrels of diesel
just now
Philippine Government Reduces Airport and Ro-ro Terminal Fees
just now